Cargando…

Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin

Bradykinin (BK) plays an important role in different physiological processes including the general preservation and modulation of vascular systems. The present study was designed in order to examine the effect of BK on isolated rat femoral artery rings and to investigate the participation of intact...

Descripción completa

Detalles Bibliográficos
Autores principales: Radenković, Miroslav, Stojanović, Marko, Skorupan, Nebojša, Prostran, Milica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Österreichische Apotheker-Verlagsgesellschaft 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791937/
https://www.ncbi.nlm.nih.gov/pubmed/24106671
http://dx.doi.org/10.3797/scipharm.1305-13
_version_ 1782286774919233536
author Radenković, Miroslav
Stojanović, Marko
Skorupan, Nebojša
Prostran, Milica
author_facet Radenković, Miroslav
Stojanović, Marko
Skorupan, Nebojša
Prostran, Milica
author_sort Radenković, Miroslav
collection PubMed
description Bradykinin (BK) plays an important role in different physiological processes including the general preservation and modulation of vascular systems. The present study was designed in order to examine the effect of BK on isolated rat femoral artery rings and to investigate the participation of intact endothelium, cyclooxygenase products, Ca(2+) channels, Na(+)/K(+)–ATPase, and B(2) kinin receptors in BK-induced action. Circular artery segments were placed in organ baths. The endothelium was mechanically removed from some arteries. Concentration–contraction curves for BK were obtained in the rings previously equilibrated at the basal tone. BK produced a concentration–dependent contraction, which was reduced by endothelial denudation. The BK–induced effect was almost completely inhibited by indomethacin (cyclooxygenase inhibitor) or OKY–046 (thromboxane A(2)–synthase inhibitor). Nifedipine (Ca(2+) channel blocker), ouabain (Na(+)/K(+)–ATPase inhibitor), or HOE–140 (selective B(2) kinin receptor antagonist) significantly reduced the BK–evoked effect. In conclusion, it can be proposed that BK produces concentration– and endothelium–dependent contractions of the isolated rat femoral artery, which is for the most part a consequence of B(2) kinin receptor activation. Cyclooxygenase contractile products, especially thromboxane A(2), play a significant role in this course of action. The transduction mechanism involved in the process of BK–induced femoral artery contraction include the activation of voltage–gated Ca(2+) channels, and in a smaller extent Na(+)/K(+)–ATPase as well.
format Online
Article
Text
id pubmed-3791937
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Österreichische Apotheker-Verlagsgesellschaft
record_format MEDLINE/PubMed
spelling pubmed-37919372013-10-08 Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin Radenković, Miroslav Stojanović, Marko Skorupan, Nebojša Prostran, Milica Sci Pharm Research Article Bradykinin (BK) plays an important role in different physiological processes including the general preservation and modulation of vascular systems. The present study was designed in order to examine the effect of BK on isolated rat femoral artery rings and to investigate the participation of intact endothelium, cyclooxygenase products, Ca(2+) channels, Na(+)/K(+)–ATPase, and B(2) kinin receptors in BK-induced action. Circular artery segments were placed in organ baths. The endothelium was mechanically removed from some arteries. Concentration–contraction curves for BK were obtained in the rings previously equilibrated at the basal tone. BK produced a concentration–dependent contraction, which was reduced by endothelial denudation. The BK–induced effect was almost completely inhibited by indomethacin (cyclooxygenase inhibitor) or OKY–046 (thromboxane A(2)–synthase inhibitor). Nifedipine (Ca(2+) channel blocker), ouabain (Na(+)/K(+)–ATPase inhibitor), or HOE–140 (selective B(2) kinin receptor antagonist) significantly reduced the BK–evoked effect. In conclusion, it can be proposed that BK produces concentration– and endothelium–dependent contractions of the isolated rat femoral artery, which is for the most part a consequence of B(2) kinin receptor activation. Cyclooxygenase contractile products, especially thromboxane A(2), play a significant role in this course of action. The transduction mechanism involved in the process of BK–induced femoral artery contraction include the activation of voltage–gated Ca(2+) channels, and in a smaller extent Na(+)/K(+)–ATPase as well. Österreichische Apotheker-Verlagsgesellschaft 2013 2013-06-04 /pmc/articles/PMC3791937/ /pubmed/24106671 http://dx.doi.org/10.3797/scipharm.1305-13 Text en © Radenković et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Radenković, Miroslav
Stojanović, Marko
Skorupan, Nebojša
Prostran, Milica
Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
title Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
title_full Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
title_fullStr Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
title_full_unstemmed Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
title_short Pharmacological Analysis of the Rat Femoral Artery Response to Bradykinin
title_sort pharmacological analysis of the rat femoral artery response to bradykinin
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3791937/
https://www.ncbi.nlm.nih.gov/pubmed/24106671
http://dx.doi.org/10.3797/scipharm.1305-13
work_keys_str_mv AT radenkovicmiroslav pharmacologicalanalysisoftheratfemoralarteryresponsetobradykinin
AT stojanovicmarko pharmacologicalanalysisoftheratfemoralarteryresponsetobradykinin
AT skorupannebojsa pharmacologicalanalysisoftheratfemoralarteryresponsetobradykinin
AT prostranmilica pharmacologicalanalysisoftheratfemoralarteryresponsetobradykinin